These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1502384

  • 1. [Immediate efficacy of bromocriptine (BrC)-LAR in the treatment of macroprolactinomas: apropos of a case].
    García Calzado MC, Ruiz Buendía A.
    Rev Clin Esp; 1992 Jun; 191(2):112-3. PubMed ID: 1502384
    [No Abstract] [Full Text] [Related]

  • 2. [Long-acting and repeatable dose bromocriptine in the prolonged treatment of prolactinoma].
    Pereira JL, García-Luna PP, Leal-Cerro A, Cortés A, Trujillo F, Villamil F, Vaquero F, Revuelta M, Astorga R.
    Med Clin (Barc); 1994 Jun 11; 103(2):59-64. PubMed ID: 8051973
    [Abstract] [Full Text] [Related]

  • 3. Long-acting injectable bromocriptine (Parlodel LAR) in the chronic treatment of prolactin-secreting macroadenomas.
    Lengyel AM, Mussio W, Imamura P, Vieira JG, Lancranjan I.
    Fertil Steril; 1993 May 11; 59(5):980-7. PubMed ID: 8486199
    [Abstract] [Full Text] [Related]

  • 4. Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas.
    Colao A, Merola B, Sarnacchiaro F, Di Sarno A, Landi ML, Marzullo P, Cerbone G, Ferone D, Lombardi G.
    Horm Res; 1995 May 11; 44(5):222-8. PubMed ID: 8582715
    [Abstract] [Full Text] [Related]

  • 5. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B, Nesher Y, Barziliai S.
    J Reprod Med; 1994 Jun 11; 39(6):449-54. PubMed ID: 7932398
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.
    Tsagarakis S, Tsiganou E, Tzavara I, Nikolou H, Thalassinos N.
    Clin Endocrinol (Oxf); 1995 Jun 11; 42(6):593-9. PubMed ID: 7634499
    [Abstract] [Full Text] [Related]

  • 7. Long-acting injectable bromocriptine treatment for macroprolactinomas.
    Van Cutsem EJ, Lamberts SW.
    Neth J Med; 1988 Apr 11; 32(3-4):112-7. PubMed ID: 3362265
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 cases.
    Beckers A, Petrossians P, Abs R, Flandroy P, Stadnik T, de Longueville M, Lancranjan I, Stevenaert A.
    J Clin Endocrinol Metab; 1992 Jul 11; 75(1):275-80. PubMed ID: 1619019
    [Abstract] [Full Text] [Related]

  • 9. Withdrawal of bromocriptine after long-term therapy for macroprolactinomas; effect on plasma prolactin and tumour size.
    van 't Verlaat JW, Croughs RJ.
    Clin Endocrinol (Oxf); 1991 Mar 11; 34(3):175-8. PubMed ID: 2036725
    [Abstract] [Full Text] [Related]

  • 10. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S, Stoeva I, Andreeva M, Kalinov K, Matrozov P, Andonova K.
    Methods Find Exp Clin Pharmacol; 1996 Nov 11; 18(9):593-7. PubMed ID: 9010834
    [Abstract] [Full Text] [Related]

  • 11. [Macroprolactinoma resistant to bromocriptine].
    López-Espinosa E, Ayala AR, Grimaldo J, Kunhardt J, Villanueva C.
    Arch Invest Med (Mex); 1989 Nov 11; 20(1):1-8. PubMed ID: 2669670
    [Abstract] [Full Text] [Related]

  • 12. [Bromocriptine for macroprolactinomas. Discussion of 3 cases treated successfully].
    Sapunar J, López JM, Huete I, Tagle R.
    Rev Med Chil; 1992 Feb 11; 120(2):168-73. PubMed ID: 1340555
    [Abstract] [Full Text] [Related]

  • 13. A case of large prolactinoma supposed to be cured by bromocriptine therapy.
    Arita K, Uozumi T, Ohta M.
    Endocrinol Jpn; 1988 Jun 11; 35(3):503-9. PubMed ID: 3197661
    [Abstract] [Full Text] [Related]

  • 14. Parlodel LAR in the treatment of macroprolactinomas.
    Kocijancic A, Prezelj J, Vrhovec I, Lancranjan I.
    Acta Endocrinol (Copenh); 1990 Feb 11; 122(2):272-6. PubMed ID: 2316314
    [Abstract] [Full Text] [Related]

  • 15. Long term therapy of patients with macroprolactinoma using repeatable injectable bromocriptine.
    Ciccarelli E, Miola C, Grottoli S, Avataneo T, Lancranjan I, Camanni F.
    J Clin Endocrinol Metab; 1993 Feb 11; 76(2):484-8. PubMed ID: 8432794
    [Abstract] [Full Text] [Related]

  • 16. Rapid and long-lasting suppression of prolactin secretion and shrinkage of prolactinomas after injection of long-acting repeatable form of bromocriptine (Parlodel LAR).
    Schettini G, Lombardi G, Merola B, Colao A, Miletto P, Caruso E, Lancranjan I.
    Clin Endocrinol (Oxf); 1990 Aug 11; 33(2):161-9. PubMed ID: 2225475
    [Abstract] [Full Text] [Related]

  • 17. Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy.
    Bronstein MD.
    Nat Clin Pract Endocrinol Metab; 2006 Mar 11; 2(3):130-1. PubMed ID: 16932269
    [No Abstract] [Full Text] [Related]

  • 18. Giant invasive prolactinoma: a case report and review of nine further cases.
    Davis JR, Sheppard MC, Heath DA.
    Q J Med; 1990 Mar 11; 74(275):227-38. PubMed ID: 2385731
    [Abstract] [Full Text] [Related]

  • 19. Treatment with long acting repeatable bromocriptine (Parlodel-LAR*) in patients with macroprolactinomas: long-term study in 29 patients.
    Jamrozik SI, Bennet AP, James-Deidier A, Tremollieres F, Saint-Martin F, Dumoulin S, Valat-Coustols M, de Glisezinski I, Tremoulet M, Manelfe C, Louvet JP.
    J Endocrinol Invest; 1996 Mar 11; 19(7):472-9. PubMed ID: 8884542
    [Abstract] [Full Text] [Related]

  • 20. High prolactin level.
    Piketty ML, Nataf F, Dilouya A, Roux FX.
    J Neurosurg; 2000 Feb 11; 92(2):368-9. PubMed ID: 10659034
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.